The artificial ventilation and anesthesia masks market size has grown strongly in recent years. It will grow from $2.32 billion in 2025 to $2.48 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to limited availability of advanced ventilation devices, rising surgical procedures, increasing icu infrastructure, growing prevalence of respiratory disorders, reliance on reusable mask solutions.
The artificial ventilation and anesthesia masks market size is expected to see strong growth in the next few years. It will grow to $3.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to technological advancements in non-invasive and invasive ventilation, increasing homecare and ambulatory respiratory services, rising geriatric population, growing demand for disposable masks, expansion of operating rooms and icu facilities globally. Major trends in the forecast period include rising demand for advanced ventilation support devices, increasing use of disposable masks to reduce cross-contamination, growing adoption of homecare and ambulatory ventilation solutions, enhanced focus on patient safety and respiratory monitoring, expansion of intensive care and emergency facilities.
The rising incidence of respiratory diseases is expected to propel the growth of the artificial ventilation and anesthesia mask market going forward. Respiratory diseases refer to conditions affecting the lungs, airways, and respiratory muscles, such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). The prevalence of these diseases is increasing due to prolonged exposure to air pollution, including fine particulate matter and toxic gases, which damage lung tissue and trigger inflammation. Artificial ventilation and anesthesia masks aid in managing respiratory diseases by delivering precise oxygen or anesthetic gases during surgeries, intensive care, or emergencies, maintaining stable respiratory function. For instance, in June 2025, according to the Office for Health Improvement and Disparities in the UK, emergency admissions for respiratory diseases in England increased by 7% between 2023 and 2024, including a 9% rise for COPD, 17% for adult asthma, and 16% for pneumonia. Therefore, the rising incidence of respiratory diseases is driving the growth of the artificial ventilation and anesthesia mask market.
Major companies operating in the global artificial ventilation and anesthesia masks market are concentrating on the development of advanced solutions, such as aerosol-reducing non-invasive ventilation (NIV) masks, to improve patient safety, limit healthcare worker exposure, and reduce the risk of airborne infections. Aerosol-reducing NIV masks use a negative-pressure gradient mechanism to capture exhaled aerosols, unlike conventional masks that permit unfiltered exhaled air to spread into the surrounding environment, thereby providing enhanced protection in high-risk clinical settings. For example, in February 2025, GaleMed Corporation, a Taiwan-based medical device manufacturer, announced a commercialization partnership with Inspir Labs, an Israel-based medical innovation company, to introduce a new NIV mask to the market, promoted as the world’s first aerosol-safe ventilation mask. The mask incorporates a dual-layer silicone cushion, where the inner layer supports patient ventilation and the outer layer is connected to suction equipment to actively collect aerosols, thereby reducing airborne contamination. Its ergonomic shape, lightweight construction, and quick-release headgear clips improve both comfort and ease of use in clinical settings.
In February 2025, GaleMed Corporation, a Taiwan-based manufacturer of respiratory and anesthesia consumables, partnered with Israel-based Inspir Labs to launch the Lumena mask. The collaboration aims to enhance non-invasive ventilation safety by reducing aerosol dispersion and protecting patients and healthcare workers worldwide.
Major companies operating in the artificial ventilation and anesthesia masks market are Cardinal Health Inc., Air Liquide Medical Systems S.A., Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies Inc., ResMed Inc., Teleflex Incorporated, Getinge AB, Fisher & Paykel Healthcare Corporation Limited, Drägerwerk AG & Co. KGaA, Ambu A/S, Hamilton Medical AG, GaleMed Corporation, Armstrong Medical Ltd., Cathwide Medical Inc., Romsons Scientific and Surgical Industries Pvt. Ltd., Trudell Medical International, Besmed Health Business Corporation, Flexicare Medical Limited, Intersurgical Ltd., O-Two Medical Technologies Inc., Hans Rudolph Inc.
North America was the largest region in the artificial ventilation and anesthesia masks market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial ventilation and anesthesia masks market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial ventilation and anesthesia masks market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the artificial ventilation and anesthesia masks market by increasing the cost of imported components such as specialized polymers, valves, and precision fittings, leading to higher production costs. Segments such as disposable masks and invasive ventilation devices are particularly affected, with regions like North America and Europe facing notable cost pressures due to import duties. While tariffs create challenges in supply chain management and pricing, they also encourage local manufacturing and innovation, enabling domestic producers to enhance production efficiency and reduce dependency on imports.
The artificial ventilation and anesthesia masks market research report is one of a series of new reports that provides artificial ventilation and anesthesia masks market statistics, including artificial ventilation and anesthesia masks industry global market size, regional shares, competitors with a artificial ventilation and anesthesia masks market share, detailed artificial ventilation and anesthesia masks market segments, market trends and opportunities, and any further data you may need to thrive in the artificial ventilation and anesthesia masks industry. This artificial ventilation and anesthesia masks market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial ventilation and anesthesia masks are medical devices designed to cover a patient’s nose and mouth, providing a sealed interface for the controlled delivery of oxygen, ambient air, or anesthetic gases during medical procedures. These masks are essential for supporting or fully managing a patient’s breathing, especially during surgeries, intensive care, or emergency interventions, ensuring respiratory stability and patient safety.
The key types of artificial ventilation and anesthesia masks are invasive ventilation masks and non-invasive ventilation masks. Invasive ventilation involves delivering air to the lungs through a tube inserted into the patient’s trachea, commonly via an endotracheal or tracheostomy tube. This category includes disposable and reusable masks and serves various end users, including operating rooms, intensive care units, emergency rooms, homecare, and ambulatory surgical centers.
The artificial ventilation and anesthesia masks market consists of sales of disposable anesthesia masks, reusable anesthesia masks, continuous positive airway pressure (CPAP) masks, bilevel positive airway pressure (BiPAP) masks, and high-flow oxygen masks. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The artificial ventilation and anesthesia masks market size is expected to see strong growth in the next few years. It will grow to $3.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to technological advancements in non-invasive and invasive ventilation, increasing homecare and ambulatory respiratory services, rising geriatric population, growing demand for disposable masks, expansion of operating rooms and icu facilities globally. Major trends in the forecast period include rising demand for advanced ventilation support devices, increasing use of disposable masks to reduce cross-contamination, growing adoption of homecare and ambulatory ventilation solutions, enhanced focus on patient safety and respiratory monitoring, expansion of intensive care and emergency facilities.
The rising incidence of respiratory diseases is expected to propel the growth of the artificial ventilation and anesthesia mask market going forward. Respiratory diseases refer to conditions affecting the lungs, airways, and respiratory muscles, such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). The prevalence of these diseases is increasing due to prolonged exposure to air pollution, including fine particulate matter and toxic gases, which damage lung tissue and trigger inflammation. Artificial ventilation and anesthesia masks aid in managing respiratory diseases by delivering precise oxygen or anesthetic gases during surgeries, intensive care, or emergencies, maintaining stable respiratory function. For instance, in June 2025, according to the Office for Health Improvement and Disparities in the UK, emergency admissions for respiratory diseases in England increased by 7% between 2023 and 2024, including a 9% rise for COPD, 17% for adult asthma, and 16% for pneumonia. Therefore, the rising incidence of respiratory diseases is driving the growth of the artificial ventilation and anesthesia mask market.
Major companies operating in the global artificial ventilation and anesthesia masks market are concentrating on the development of advanced solutions, such as aerosol-reducing non-invasive ventilation (NIV) masks, to improve patient safety, limit healthcare worker exposure, and reduce the risk of airborne infections. Aerosol-reducing NIV masks use a negative-pressure gradient mechanism to capture exhaled aerosols, unlike conventional masks that permit unfiltered exhaled air to spread into the surrounding environment, thereby providing enhanced protection in high-risk clinical settings. For example, in February 2025, GaleMed Corporation, a Taiwan-based medical device manufacturer, announced a commercialization partnership with Inspir Labs, an Israel-based medical innovation company, to introduce a new NIV mask to the market, promoted as the world’s first aerosol-safe ventilation mask. The mask incorporates a dual-layer silicone cushion, where the inner layer supports patient ventilation and the outer layer is connected to suction equipment to actively collect aerosols, thereby reducing airborne contamination. Its ergonomic shape, lightweight construction, and quick-release headgear clips improve both comfort and ease of use in clinical settings.
In February 2025, GaleMed Corporation, a Taiwan-based manufacturer of respiratory and anesthesia consumables, partnered with Israel-based Inspir Labs to launch the Lumena mask. The collaboration aims to enhance non-invasive ventilation safety by reducing aerosol dispersion and protecting patients and healthcare workers worldwide.
Major companies operating in the artificial ventilation and anesthesia masks market are Cardinal Health Inc., Air Liquide Medical Systems S.A., Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies Inc., ResMed Inc., Teleflex Incorporated, Getinge AB, Fisher & Paykel Healthcare Corporation Limited, Drägerwerk AG & Co. KGaA, Ambu A/S, Hamilton Medical AG, GaleMed Corporation, Armstrong Medical Ltd., Cathwide Medical Inc., Romsons Scientific and Surgical Industries Pvt. Ltd., Trudell Medical International, Besmed Health Business Corporation, Flexicare Medical Limited, Intersurgical Ltd., O-Two Medical Technologies Inc., Hans Rudolph Inc.
North America was the largest region in the artificial ventilation and anesthesia masks market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial ventilation and anesthesia masks market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial ventilation and anesthesia masks market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the artificial ventilation and anesthesia masks market by increasing the cost of imported components such as specialized polymers, valves, and precision fittings, leading to higher production costs. Segments such as disposable masks and invasive ventilation devices are particularly affected, with regions like North America and Europe facing notable cost pressures due to import duties. While tariffs create challenges in supply chain management and pricing, they also encourage local manufacturing and innovation, enabling domestic producers to enhance production efficiency and reduce dependency on imports.
The artificial ventilation and anesthesia masks market research report is one of a series of new reports that provides artificial ventilation and anesthesia masks market statistics, including artificial ventilation and anesthesia masks industry global market size, regional shares, competitors with a artificial ventilation and anesthesia masks market share, detailed artificial ventilation and anesthesia masks market segments, market trends and opportunities, and any further data you may need to thrive in the artificial ventilation and anesthesia masks industry. This artificial ventilation and anesthesia masks market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial ventilation and anesthesia masks are medical devices designed to cover a patient’s nose and mouth, providing a sealed interface for the controlled delivery of oxygen, ambient air, or anesthetic gases during medical procedures. These masks are essential for supporting or fully managing a patient’s breathing, especially during surgeries, intensive care, or emergency interventions, ensuring respiratory stability and patient safety.
The key types of artificial ventilation and anesthesia masks are invasive ventilation masks and non-invasive ventilation masks. Invasive ventilation involves delivering air to the lungs through a tube inserted into the patient’s trachea, commonly via an endotracheal or tracheostomy tube. This category includes disposable and reusable masks and serves various end users, including operating rooms, intensive care units, emergency rooms, homecare, and ambulatory surgical centers.
The artificial ventilation and anesthesia masks market consists of sales of disposable anesthesia masks, reusable anesthesia masks, continuous positive airway pressure (CPAP) masks, bilevel positive airway pressure (BiPAP) masks, and high-flow oxygen masks. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Artificial Ventilation and Anesthesia Masks Market Characteristics
3. Artificial Ventilation and Anesthesia Masks Market Supply Chain Analysis
4. Global Artificial Ventilation and Anesthesia Masks Market Trends and Strategies
5. Artificial Ventilation and Anesthesia Masks Market Analysis of End Use Industries
7. Global Artificial Ventilation and Anesthesia Masks Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Artificial Ventilation and Anesthesia Masks Total Addressable Market (TAM) Analysis for the Market
9. Artificial Ventilation and Anesthesia Masks Market Segmentation
10. Artificial Ventilation and Anesthesia Masks Market Regional and Country Analysis
11. Asia-Pacific Artificial Ventilation and Anesthesia Masks Market
12. China Artificial Ventilation and Anesthesia Masks Market
13. India Artificial Ventilation and Anesthesia Masks Market
14. Japan Artificial Ventilation and Anesthesia Masks Market
15. Australia Artificial Ventilation and Anesthesia Masks Market
16. Indonesia Artificial Ventilation and Anesthesia Masks Market
17. South Korea Artificial Ventilation and Anesthesia Masks Market
18. Taiwan Artificial Ventilation and Anesthesia Masks Market
19. South East Asia Artificial Ventilation and Anesthesia Masks Market
20. Western Europe Artificial Ventilation and Anesthesia Masks Market
21. UK Artificial Ventilation and Anesthesia Masks Market
22. Germany Artificial Ventilation and Anesthesia Masks Market
23. France Artificial Ventilation and Anesthesia Masks Market
24. Italy Artificial Ventilation and Anesthesia Masks Market
25. Spain Artificial Ventilation and Anesthesia Masks Market
26. Eastern Europe Artificial Ventilation and Anesthesia Masks Market
27. Russia Artificial Ventilation and Anesthesia Masks Market
28. North America Artificial Ventilation and Anesthesia Masks Market
29. USA Artificial Ventilation and Anesthesia Masks Market
30. Canada Artificial Ventilation and Anesthesia Masks Market
31. South America Artificial Ventilation and Anesthesia Masks Market
32. Brazil Artificial Ventilation and Anesthesia Masks Market
33. Middle East Artificial Ventilation and Anesthesia Masks Market
34. Africa Artificial Ventilation and Anesthesia Masks Market
36. Artificial Ventilation and Anesthesia Masks Market Competitive Landscape and Company Profiles
37. Artificial Ventilation and Anesthesia Masks Market Other Major and Innovative Companies
40. Artificial Ventilation and Anesthesia Masks Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Artificial Ventilation And Anesthesia Masks Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial ventilation and anesthesia masks market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial ventilation and anesthesia masks? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial ventilation and anesthesia masks market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Invasive Ventilation; Non-Invasive Ventilation2) By Mask Type: Disposable Masks; Reusable Masks
3) By Application: Operating Rooms; Intensive Care Unit; Emergency Rooms; Homecare; Ambulatory Surgical Centers
Subsegments:
1) By Invasive Ventilation: Volume Controlled Ventilation; Pressure Controlled Ventilation; Pressure Support Ventilation; Synchronized Intermittent Mandatory Ventilation; High Frequency Oscillatory Ventilation2) By Non-Invasive Ventilation: Continuous Positive Airway Pressure; Bilevel Positive Airway Pressure; Volume Assured Pressure Support; Negative Pressure Ventilation; Proportional Assist Ventilation
Companies Mentioned: Cardinal Health Inc.; Air Liquide Medical Systems S.A.; Medtronic plc; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; ResMed Inc.; Teleflex Incorporated; Getinge AB; Fisher & Paykel Healthcare Corporation Limited; Drägerwerk AG & Co. KGaA; Ambu A/S; Hamilton Medical AG; GaleMed Corporation; Armstrong Medical Ltd.; Cathwide Medical Inc.; Romsons Scientific and Surgical Industries Pvt. Ltd.; Trudell Medical International; Besmed Health Business Corporation; Flexicare Medical Limited; Intersurgical Ltd.; O-Two Medical Technologies Inc.; Hans Rudolph Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Artificial Ventilation and Anesthesia Masks market report include:- Cardinal Health Inc.
- Air Liquide Medical Systems S.A.
- Medtronic plc
- Koninklijke Philips N.V.
- GE Healthcare Technologies Inc.
- ResMed Inc.
- Teleflex Incorporated
- Getinge AB
- Fisher & Paykel Healthcare Corporation Limited
- Drägerwerk AG & Co. KGaA
- Ambu A/S
- Hamilton Medical AG
- GaleMed Corporation
- Armstrong Medical Ltd.
- Cathwide Medical Inc.
- Romsons Scientific and Surgical Industries Pvt. Ltd.
- Trudell Medical International
- Besmed Health Business Corporation
- Flexicare Medical Limited
- Intersurgical Ltd.
- O-Two Medical Technologies Inc.
- Hans Rudolph Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.48 Billion |
| Forecasted Market Value ( USD | $ 3.18 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
